• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Development and validation of the predictive score for pediatric COVID-19 pneumonia: A nationwide, multicenter study.儿童 COVID-19 肺炎预测评分的制定和验证:一项全国性多中心研究。
PLoS One. 2022 Aug 29;17(8):e0273842. doi: 10.1371/journal.pone.0273842. eCollection 2022.
2
External Validation of the ISAN, A2DS2, and AIS-APS Scores for Predicting Stroke-Associated Pneumonia.ISAN、A2DS2和AIS-APS评分预测卒中相关性肺炎的外部验证
J Stroke Cerebrovasc Dis. 2018 Mar;27(3):673-676. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.059. Epub 2017 Nov 2.
3
Development and external validation of a prediction risk model for short-term mortality among hospitalized U.S. COVID-19 patients: A proposal for the COVID-AID risk tool.美国住院 COVID-19 患者短期死亡率预测风险模型的开发和外部验证:COVID-AID 风险工具的建议。
PLoS One. 2020 Sep 30;15(9):e0239536. doi: 10.1371/journal.pone.0239536. eCollection 2020.
4
An epidemiological study of pediatric COVID-19 in the era of the variant of concern.关注变异株时期的儿童 COVID-19 流行病学研究。
PLoS One. 2022 Apr 15;17(4):e0267035. doi: 10.1371/journal.pone.0267035. eCollection 2022.
5
Development and validation of a clinical predictive model for severe and critical pediatric COVID-19 infection.开发和验证一种用于严重和危重新冠肺炎儿童感染的临床预测模型。
PLoS One. 2022 Oct 27;17(10):e0275761. doi: 10.1371/journal.pone.0275761. eCollection 2022.
6
Derivation and Validation of a Clinical Prediction Score to Identify the Isolation of Pseudomonas in Pneumonia.临床预测评分的推导和验证,以确定肺炎中铜绿假单胞菌的分离。
Microbiol Spectr. 2022 Jun 29;10(3):e0042422. doi: 10.1128/spectrum.00424-22. Epub 2022 May 23.
7
Development of lab score system for predicting COVID-19 patient severity: A retrospective analysis.实验室评分系统预测 COVID-19 患者严重程度的开发:一项回顾性分析。
PLoS One. 2022 Sep 9;17(9):e0273006. doi: 10.1371/journal.pone.0273006. eCollection 2022.
8
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.开发和验证一种临床风险评分,以预测 COVID-19 住院患者发生危重症的情况。
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089. doi: 10.1001/jamainternmed.2020.2033.
9
Development and validation of a simple risk score for diagnosing COVID-19 in the emergency room.开发和验证一种用于急诊科诊断 COVID-19 的简单风险评分。
Epidemiol Infect. 2020 Nov 13;148:e273. doi: 10.1017/S0950268820002769.
10
Risk Factors and a Scoring System to Predict ARDS in Patients with COVID-19 Pneumonia in Korea: A Multicenter Cohort Study.韩国一项多中心队列研究:预测 COVID-19 肺炎患者发生 ARDS 的危险因素和评分系统。
Dis Markers. 2021 Apr 9;2021:8821697. doi: 10.1155/2021/8821697. eCollection 2021.

引用本文的文献

1
Chest X-ray findings of COVID-19 pneumonia in children: Experiences in a multicenter study in Thailand.儿童 COVID-19 肺炎的胸部 X 线表现:泰国多中心研究的经验。
PLoS One. 2024 Sep 30;19(9):e0309110. doi: 10.1371/journal.pone.0309110. eCollection 2024.
2
Clinical Characteristics and Outcomes of Pediatric COVID-19 Pneumonia Treated with Favipiravir in a Tertiary Care Center.在一家三级保健中心用珐匹拉韦治疗儿童 COVID-19 肺炎的临床特征和结局。
Viruses. 2024 Jun 12;16(6):946. doi: 10.3390/v16060946.
3
Antibodies against SARS-CoV-2 in unvaccinated children hospitalized with COVID-19: An observational cohort study of pre-Omicron and Omicron variants era.未接种疫苗的 COVID-19 住院患儿体内的 SARS-CoV-2 抗体:奥密克戎变异株前和奥密克戎变异株时代的观察性队列研究。
PLoS One. 2024 Feb 23;19(2):e0297991. doi: 10.1371/journal.pone.0297991. eCollection 2024.
4
Characteristics and Risk Factors Associated with SARS-CoV-2 Pneumonias in Hospitalized Pediatric Patients: A Pilot Study.住院儿科患者中与新型冠状病毒肺炎相关的特征和危险因素:一项初步研究。
Children (Basel). 2023 Oct 19;10(10):1703. doi: 10.3390/children10101703.

本文引用的文献

1
Clinical outcomes of pediatric COVID-19 in a tertiary care center in Bangkok, Thailand.泰国曼谷一家三级护理中心儿童新冠病毒病的临床结局
IJID Reg. 2021 Dec;1:159-162. doi: 10.1016/j.ijregi.2021.11.003. Epub 2021 Nov 18.
2
Comparison of the First and Second Waves of the Coronavirus Disease 2019 Pandemic in Children and Adolescents in a Middle-Income Country: Clinical Impact Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Gamma Lineage.比较中低收入国家儿童和青少年 2019 冠状病毒病 2019 年大流行的第一波和第二波:与严重急性呼吸综合征冠状病毒 2 伽马谱系相关的临床影响。
J Pediatr. 2022 May;244:178-185.e3. doi: 10.1016/j.jpeds.2022.01.001. Epub 2022 Jan 11.
3
Clinical Picture and Risk Factors of Severe Respiratory Symptoms in COVID-19 in Children.儿童 COVID-19 严重呼吸道症状的临床特征和危险因素。
Viruses. 2021 Nov 25;13(12):2366. doi: 10.3390/v13122366.
4
Risk factors associated with SARS-CoV-2 pneumonia in the pediatric population.与儿童人群中 SARS-CoV-2 肺炎相关的风险因素。
Bol Med Hosp Infant Mex. 2021;78(4):251-258. doi: 10.24875/BMHIM.20000263.
5
Comparative Analysis of Pediatric COVID-19 Infection in Southeast Asia, South Asia, Japan, and China.东南亚、南亚、日本和中国儿童 COVID-19 感染的比较分析。
Am J Trop Med Hyg. 2021 Jun 15;105(2):413-420. doi: 10.4269/ajtmh.21-0299.
6
Risk profiles of severe illness in children with COVID-19: a meta-analysis of individual patients.儿童 COVID-19 重症风险特征:一项个体患者的荟萃分析。
Pediatr Res. 2021 Aug;90(2):347-352. doi: 10.1038/s41390-021-01429-2. Epub 2021 Mar 22.
7
Clinical characteristics, treatment and outcomes of paediatric COVID-19: a systematic review and meta-analysis.儿童 COVID-19 的临床特征、治疗和结局:系统评价和荟萃分析。
Arch Dis Child. 2021 Apr 21;106(5):440-448. doi: 10.1136/archdischild-2020-321385.
8
Risk Factors for Severe COVID-19 in Children.儿童重症 COVID-19 的危险因素。
Pediatr Infect Dis J. 2021 Apr 1;40(4):e137-e145. doi: 10.1097/INF.0000000000003043.
9
Improving clinical management of COVID-19: the role of prediction models.改善新型冠状病毒肺炎的临床管理:预测模型的作用
Lancet Respir Med. 2021 Apr;9(4):320-321. doi: 10.1016/S2213-2600(21)00006-0. Epub 2021 Jan 11.
10
Prevalence, clinical characteristics, and outcomes of pediatric COVID-19: A systematic review and meta-analysis.儿童 COVID-19 的患病率、临床特征和结局:系统评价和荟萃分析。
J Clin Virol. 2021 Feb;135:104715. doi: 10.1016/j.jcv.2020.104715. Epub 2020 Dec 8.

儿童 COVID-19 肺炎预测评分的制定和验证:一项全国性多中心研究。

Development and validation of the predictive score for pediatric COVID-19 pneumonia: A nationwide, multicenter study.

机构信息

Department of Pediatrics, Faculty of Medicine, Thammasat University Hospital, Thammasat University, Pathumthani, Thailand.

Department of Pediatrics, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

出版信息

PLoS One. 2022 Aug 29;17(8):e0273842. doi: 10.1371/journal.pone.0273842. eCollection 2022.

DOI:10.1371/journal.pone.0273842
PMID:36037228
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9423652/
Abstract

BACKGROUND

Due to the possibility of asymptomatic pneumonia in children with COVID-19 leading to overexposure to radiation and problems in limited-resource settings, we conducted a nationwide, multi-center study to determine the risk factors of pneumonia in children with COVID-19 in order to create a pediatric pneumonia predictive score, with score validation.

METHODS

This was a retrospective cohort study done by chart review of all children aged 0-15 years admitted to 13 medical centers across Thailand during the study period. Univariate and multivariate analyses as well as backward and forward stepwise logistic regression were used to generate a final prediction model of the pneumonia score. Data during the pre-Delta era was used to create a prediction model whilst data from the Delta one was used as a validation cohort.

RESULTS

The score development cohort consisted of 1,076 patients in the pre-Delta era, and the validation cohort included 2,856 patients in the Delta one. Four predictors remained after backward and forward stepwise logistic regression: age < 5 years, number of comorbidities, fever, and dyspnea symptoms. The predictive ability of the novel pneumonia score was acceptable with the area under the receiver operating characteristics curve of 0.677 and a well-calibrated goodness-of-fit test (p = 0.098). The positive likelihood ratio for pneumonia was 0.544 (95% confidence interval (CI): 0.491-0.602) in the low-risk category, 1.563 (95% CI: 1.454-1.679) in the moderate, and 4.339 (95% CI: 2.527-7.449) in the high-risk.

CONCLUSION

This study created an acceptable clinical prediction model which can aid clinicians in performing an appropriate triage for children with COVID-19.

摘要

背景

由于 COVID-19 患儿可能出现无症状肺炎,导致过度暴露于辐射下,且在资源有限的环境中存在问题,因此我们开展了一项全国性、多中心研究,以确定 COVID-19 患儿肺炎的危险因素,从而制定出小儿肺炎预测评分,并进行评分验证。

方法

这是一项回顾性队列研究,通过对研究期间泰国 13 家医疗中心收治的所有 0-15 岁儿童的病历进行回顾性分析。使用单因素和多因素分析以及向后和向前逐步逻辑回归来生成肺炎评分的最终预测模型。使用前德尔塔时代的数据来创建预测模型,而使用德尔塔时代的数据作为验证队列。

结果

评分开发队列包括前德尔塔时代的 1076 例患者,验证队列包括德尔塔时代的 2856 例患者。经过向后和向前逐步逻辑回归,有 4 个预测因子仍然存在:年龄<5 岁、合并症数量、发热和呼吸困难症状。新型肺炎评分的预测能力可接受,接受者操作特征曲线下面积为 0.677,拟合优度检验良好(p=0.098)。低危组肺炎的阳性似然比为 0.544(95%置信区间:0.491-0.602),中危组为 1.563(95%置信区间:1.454-1.679),高危组为 4.339(95%置信区间:2.527-7.449)。

结论

本研究创建了一个可接受的临床预测模型,可帮助临床医生对 COVID-19 患儿进行适当分诊。